Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,122
Total Claims
$1.5M
Drug Cost
1,386
Beneficiaries
$1,107
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+65%
Opioid rate vs peers
3.7% vs 2.2% avg
-22%
Cost per patient vs peers
$1,107 vs $1,411 avg
+8%
Brand preference vs peers
11.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.7%
Opioid Rate
706
Opioid Claims
$5,502
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,167 claims · $1.3M
Generic: 16,792 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 188 | $249K |
| Apixaban | 178 | $144K |
| Sitagliptin Phosphate | 85 | $91K |
| Insulin Glargine,hum.Rec.Anlog | 136 | $72K |
| Dapagliflozin Propanediol | 76 | $69K |
| Empagliflozin | 76 | $67K |
| Dulaglutide | 39 | $51K |
| Fluticasone/Umeclidin/Vilanter | 69 | $51K |
| Tirzepatide | 40 | $47K |
| Rivaroxaban | 26 | $34K |
| Insulin Detemir | 44 | $33K |
| Mirabegron | 20 | $28K |
| Linaclotide | 41 | $25K |
| Budesonide/Formoterol Fumarate | 38 | $25K |
| Sacubitril/Valsartan | 13 | $19K |
Prescribing Profile
Patient Profile
74
Avg Age
58%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About